Literature DB >> 9339151

NKF-DOQI clinical practice guidelines for the treatment of anemia of chronic renal failure. National Kidney Foundation-Dialysis Outcomes Quality Initiative.

.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9339151

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


× No keyword cloud information.
  48 in total

Review 1.  Chronic renal disease.

Authors:  Malvinder S Parmar
Journal:  BMJ       Date:  2002-07-13

2.  Why multidisciplinary clinics should be the standard for treating chronic kidney disease.

Authors:  Guido Filler; Steven E Lipshultz
Journal:  Pediatr Nephrol       Date:  2012-07-04       Impact factor: 3.714

Review 3.  Medical safety in the care of the person with end-stage kidney disease.

Authors:  John V Duronville; Clarissa J Diamantidis
Journal:  Semin Dial       Date:  2018-01-07       Impact factor: 3.455

Review 4.  The clinical trial imperative.

Authors:  Debbie Gipson; Howard Trachtman
Journal:  Pediatr Nephrol       Date:  2004-11-25       Impact factor: 3.714

Review 5.  Characteristics of the clinical practice patterns of hemodialysis in Japan in consideration of DOPPS and the NKF/DOQI guidelines.

Authors:  Satoru Kuriyama
Journal:  Clin Exp Nephrol       Date:  2008-01-09       Impact factor: 2.801

6.  Trends in anemia care in older patients approaching end-stage renal disease in the United States (1995-2010).

Authors:  Wolfgang C Winkelmayer; Aya A Mitani; Benjamin A Goldstein; M Alan Brookhart; Glenn M Chertow
Journal:  JAMA Intern Med       Date:  2014-05       Impact factor: 21.873

7.  Epoetin alfa and intravenous iron sucrose to treat severe anemia in a patient with chronic radiation enteropathy: a case report.

Authors:  Sophie Séronie-Vivien; Loïc Mourey; Moustapha Tohfe; Roland Bugat
Journal:  Med Oncol       Date:  2003       Impact factor: 3.064

8.  The Healthy People 2020 Objectives for Kidney Disease: How Far Have We Come, and Where Do We Need to Go?

Authors:  James B Wetmore; Jiannong Liu; Suying Li; Yan Hu; Yi Peng; David T Gilbertson; Allan J Collins
Journal:  Clin J Am Soc Nephrol       Date:  2016-08-30       Impact factor: 8.237

Review 9.  Use of agents stimulating erythropoiesis in digestive diseases.

Authors:  Rosario Moreno López; Beatriz Sicilia Aladrén; Fernando Gomollón García
Journal:  World J Gastroenterol       Date:  2009-10-07       Impact factor: 5.742

Review 10.  Kidney disease: improving global outcomes.

Authors:  Kai-Uwe Eckardt; Bertram L Kasiske
Journal:  Nat Rev Nephrol       Date:  2009-09-29       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.